The global burden of disease attributable to contaminated injections given in health care settings.
about
Injection drug use, unsafe medical injections, and HIV in Africa: a systematic reviewEpidemiology of hepatitis C virus infectionHepatitis C: a review for primary care physiciansGenetic history of hepatitis C virus in East AsiaAssociation between injections and HIV incidenceRapid assessment of injection practices in Cambodia, 2002.Safer injections following a new national medicine policy in the public sector, Burkina Faso 1995-2000Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?Assessment of Knowledge and Practices regarding Injection Safety and Related Biomedical Waste Management amongst Interns in a Tertiary Care Teaching Hospital, DelhiHepatitis B and hepatitis C in Pakistan: prevalence and risk factorsBest strategies for global HCV eradication.The current hepatitis C virus prevalence in China may have resulted mainly from an officially encouraged plasma campaign in the 1990s: a coalescence inference with genetic sequencesGlobal epidemiology and burden of HCV infection and HCV-related disease.Towards safe injection practices for prevention of hepatitis C transmission in South Asia: Challenges and progress.Uncovering high rates of unsafe injection equipment reuse in rural Cameroon: validation of a survey instrument that probes for specific misconceptions.Global report on preterm birth and stillbirth (4 of 7): delivery of interventionsEvolution of the global burden of viral infections from unsafe medical injections, 2000-2010.Protective immunity against hepatitis C: many shades of gray.Syringe free vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles provides strong and prolonged protection against tuberculosis.Evaluation of the patient with hepatitis BA comprehensive situation assessment of injection practices in primary health care hospitals in BangladeshEffect of microneedle design on pain in human volunteers.Dissolving microneedle patch for transdermal delivery of human growth hormone.Evidence of intense ongoing endemic transmission of hepatitis C virus in EgyptPotential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.Phylogeography, risk factors and genetic history of hepatitis C virus in Gabon, central Africa.Highly endemic hepatitis B infection in rural Vietnam.Parenteral medication prescriptions, dispensing and administration habits in MongoliaWill there be a vaccine to prevent HCV infection?How often are major blood-borne pathogens found in eye patients? A serosurvey at an eye hospital in Southern China.Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccinesEvolution of the global use of unsafe medical injections, 2000-2010Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic review.Evidence-based clinical guidelines for immigrants and refugees.Serodiagnosis for tumor viruses.A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.Management of hepatitis B in developing countries.Prospects for dendritic cell vaccination in persistent infection with hepatitis C virusMicroneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
P2860
Q21245626-A7305505-0C2E-4441-9231-4E3D6954C5AAQ22305500-2E0A39DC-B128-47C5-B932-D4ACBA1E6671Q22306040-3B286CD9-C008-44B5-9055-9C0AF50945ACQ24655361-08DCAADB-F39D-48CF-A6AD-FA69A95B948EQ24810067-AB751588-F3C8-4CDF-A5B5-B07A2CCF8B5CQ24815741-94FC84EF-BF5A-4DBA-8E0C-BBBFEBFFCDF2Q25256738-2B818EA5-7D86-44A2-8141-E0024C67A3F8Q26801828-125B8A0D-BB89-4A93-A5AC-0D6ECAF24892Q27316287-C06B18C2-F175-4532-8120-57A179BB5F20Q27488116-9AA415B2-3541-4997-AE4F-5B4A64618152Q27693824-185DE098-73CD-47BA-AF10-3AFCC6688860Q28662145-205AE215-B192-42F2-9D55-8952F52FB69CQ30240220-CC8FA299-C226-4D37-A99E-7AFFD5D7930CQ30390712-82B2157D-A1B5-4B10-AC7E-C2F9FB3BD9F3Q30498212-65D24DE3-AFBE-4290-AAC2-542408E22C51Q33541221-DD69CED0-B64A-4CE9-8DD3-0D4AF208D947Q33727801-A4618D51-CE90-4A40-9D3A-DC5A2D689291Q33759224-55573D1C-93B6-49DF-B10D-AA69B1885F3AQ33760570-24E20EDD-E7BA-47F7-AFC3-5F85046674F0Q33896660-22DACF3C-8C9E-4648-B0E1-297DDC1D1371Q34045290-BFD4E4F6-029A-4DC1-924A-483F53E5946BQ34048990-D2BAB4C4-B781-4FB0-9C2F-CBDBDDBCCD4EQ34083733-9B12A1E4-9D45-40AA-A112-34F1C04DF6A7Q34093173-205DDD43-BF2C-4654-9680-84C9430B17F8Q34255407-AD7414F6-F1C4-4B04-8DDF-68452C1A690BQ34288194-5BB8A2E4-726E-4D08-AE5F-1A58469516D8Q34369200-463CEC8D-9B8B-43F8-99AF-27D0ED494D60Q34655011-60AB6DFA-FEE9-4F76-8EA1-2F88989685C9Q34757074-9A3144DC-757E-4060-AB95-1581AE77F750Q34781537-6390F728-2C6C-4FC5-8EBF-80342D3563BFQ34984617-7488F001-4107-4619-A8B6-C535F302458FQ35049480-9BE055B3-1AA0-4B4B-99E2-47AD87D6E07FQ35063841-B5516352-6336-4761-BE39-6D2A58ED8180Q35108552-C487410A-049E-4887-A79B-632F6DB079C3Q35201293-4BBE1B77-64B0-43BF-AD14-2C52FCB312B5Q35289576-00DB657A-965F-4EA1-9B1D-59AD67483694Q35579175-94BF7118-8977-4D60-B611-D1E884E5C8C5Q35635637-CB91A416-5AC3-4731-A0E4-D9185701991EQ35784239-21735636-E6DA-4EA1-A9A5-BBA4E6A87DC3Q35811003-6291D7C6-053A-4910-817E-C8F33684ED12
P2860
The global burden of disease attributable to contaminated injections given in health care settings.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
The global burden of disease a ...... given in health care settings.
@en
The global burden of disease a ...... given in health care settings.
@nl
type
label
The global burden of disease a ...... given in health care settings.
@en
The global burden of disease a ...... given in health care settings.
@nl
prefLabel
The global burden of disease a ...... given in health care settings.
@en
The global burden of disease a ...... given in health care settings.
@nl
P2093
P1476
The global burden of disease a ...... given in health care settings.
@en
P2093
Anja M Hauri
Gregory L Armstrong
Yvan J F Hutin
P356
10.1258/095646204322637182
P577
2004-01-01T00:00:00Z